European Archives - Page 365 of 1054 - European Medical Journal

Behind the Scenes of Healthcare

Bruce Gewertz joins Jonathan in this episode of the EMJ Podcast to discuss work-life balance in medicine and the steps to optimising leadership

RSV drug nirsevimab chases FDA approval

A drug to treat infants with RSV is on its pathway to approval in the US following a successful Biologics License Application to the FDA.

Robotic PCI: Technology Overview, New Clinical Evidence, and Future Possibilities

This webinar explores robotic percutaneous coronary intervention (PCI). Constantin von zur Mühlen, University Heart Center Freiburg, Bad Krozingen, Germany, will discuss the establishment of robotic-assisted PCI in Europe, its challenges, and opportunities at a tertiary referral centre.

5 minutes with Gen Li, President, Phesi

5 minutes with Gen Li, President of clinical trial database company Phesi.

Wound Healing in a Time of Antimicrobial Resistance

Karen Ousey joins Jonathan Sackier on this episode of the EMJ Podcast to discuss antimicrobial resistance and wound healing.

Editor's Letter: December 2022

Pharma should double down on its patient centricity efforts to help tackle inequalities in 2023 and beyond, says Helena Beer.

Pharma review of the year 2022

Helena and Isabel are joined by six guests to round off 2022 and Season 3 with a look back at the key highlights of the past 12 months.

EMJ Gastroenterology 11 [Supplement 9] 2022

This poster review article summarised selected original research covering recent advances in the management of various gastrointestinal diseases, including inflammatory bowel disease, disorders of gut–brain interactions, gastro-oesophageal reflux disease, and pancreatic disorders, presented at the United European Gastroenterology (UEG) Week, which took place in Vienna, Austria, between 8th–11th October 2022.

Recent Advances in the Management of Gastrointestinal Disease

Interdisciplinary sessions at the recent United European Gastroenterology (UEG) Week, held in Vienna, Austria, from 8th to 11th October 2022, covered new approaches to the diagnosis and treatment of gastrointestinal and hepatic disorders, with a focus on advances in the non-invasive management of these diseases. Abstract-based and poster sessions presented original research from Europe and other parts of the world.

EMJ Hepatology 10 [Supplement 4] 2022

This symposium took place at the European Association for the Study of the Liver (EASL) International Liver Congress (ILC) 2022, where experts highlighted the importance of communication between healthcare professionals (HCP) and patients with hepatitis B.